HUB Investment Partners, LLC’s portfolio moves, tracked quarter by quarter through its SEC Form 13F filings. Like other superinvestor portfolio updates followed on this site, this profile compiles what the fund reports each quarter to the SEC on its U.S. equity and fund holdings, giving a running picture of how the firm’s positioning shifts over … Read more
A new Periodic Transaction Report filed with the U.S. House of Representatives shows Rep. Julia Letlow purchased shares of AbbVie Inc. (ABBV) common stock on April 28, 2025. The transaction was made personally by the member of Congress, not through a spouse or dependent, and is valued in the disclosed range of $1,001 to $15,000. … Read more
This page follows OSSIAM’s institutional portfolio moves as disclosed in its SEC Form 13F filings, updated every quarter as new data becomes available. Rather than a one-time snapshot, it’s built to be a running record of what the fund has been buying, trimming, and starting fresh with over time — a reference point for anyone … Read more
A new Periodic Transaction Report shows Rep. Julia Letlow (R-La.) sold shares of AbbVie Inc. (ABBV) common stock on January 24, 2025. The transaction was disclosed in a filing with the U.S. House of Representatives and is valued in the $1,001 to $15,000 range, the smallest bracket used on STOCK Act disclosure forms. The sale … Read more
A new disclosure filed with the U.S. House of Representatives shows that Rep. Julia Letlow purchased shares of AbbVie Inc. (ABBV) common stock, according to a Periodic Transaction Report submitted under the STOCK Act. The transaction is logged in our system as a congress buy signal. The report lists the transaction date as October 23, … Read more
This page tracks Defilade Capital Management, L.P.’s institutional portfolio moves as disclosed in its SEC Form 13F filings, updated every quarter as new filings become available. Because 13F filings report only quarter-end snapshots rather than exact trade dates, all activity below is described as occurring during the quarter ending 2026-03-31, and future updates will build … Read more
This page follows Sofinnova Investments, Inc.’s institutional portfolio as disclosed in its quarterly Form 13F filings with the SEC. A Form 13F is a required filing for institutional investment managers overseeing more than $100 million in U.S. equities, and it offers a snapshot of long positions held at the end of each quarter — not … Read more